A Senate Standing Committee on Health report now recommends the disposal of medical supplies purchased by the Kenya Medical Supplies Authority (KEMSA) to combat COVID-19. – By Gerald Gekara.
The predicted loss to KEMSA if the commodities are sold now is around Ksh.2.9 billion, and the research cautions that the number may lower over time as market prices continue to fall.
In its investigation, the committee discovered that the products purchased by KEMSA to combat the COVID-19 pandemic cost the taxpayer Ksh.7.6 billion, with the majority of it worth Ksh.5.9 billion still lying in the State agency’s warehouses and only health products worth Ksh.1.8 billion having been sold.
